WARNING ON AVANDIA ♦ INCREASED RISK OF HEART ATTACK ♦
NATIONAL – In a recent article in the New England Journal of Medicine announced that, finally, the FDA has stepped forward and decided on regulatory action for Avandia, a diabetes drug that last year claimed 1,354 lives as a result of cardiac-associated problems. The FDA is restricting access to Avandia by requiring GSK to submit…